Crabel Capital Management’s Pfizer PFE Stock Holding History

Crabel Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$538K	Buy	+22,355	New	+$585K	0.39%	34
2026 Q1	–	Sell	-21,346	Closed	-$532K	–	43
2025 Q4	$532K	Sell	21,346 -1,032	-5%	-$26K	0.4%	34
2025 Q3	$570K	Buy	+22,378	New	+$552K	0.51%	34
2023 Q4	–	Sell	-13,513	Closed	-$448K	–	143
2023 Q3	$448K	Sell	13,513 -15,767	-54%	-$558K	0.36%	52
2023 Q2	$1.07M	Buy	+29,280	New	+$1.14M	0.44%	46
2023 Q1	–	Sell	-5,418	Closed	-$278K	–	93
2022 Q4	$278K	Buy	+5,418	New	+$260K	0.1%	82
2022 Q2	–	Sell	-5,109	Closed	-$264K	–	94
2022 Q1	$264K	Buy	+5,109	New	+$265K	0.08%	96
2021 Q4	–	Sell	-5,971	Closed	-$257K	–	146
2021 Q3	$257K	Sell	5,971 -1,021	-15%	-$45.2K	0.08%	100
2021 Q2	$274K	Buy	+6,992	New	+$272K	0.06%	103
2021 Q1	–	Sell	-7,765	Closed	-$286K	–	117
2020 Q4	$286K	Buy	+7,765	New	+$285K	0.07%	73
2020 Q3	–	Sell	-8,749	Closed	-$271K	–	57
2020 Q2	$271K	Buy	+8,749	New	+$297K	1.16%	27
2020 Q1	–	Sell	-8,641	Closed	-$321K	–	127
2019 Q4	$321K	Buy	+8,641	New	+$308K	0.12%	124

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Crabel Capital Management's PFE Position: Q2 2026 in Review

Crabel Capital Management opened a new position in Pfizer (PFE) in Q2 2026: 22,355 shares worth $538K. The stake represents 0.39% of the portfolio and ranks #34 among its holdings. This is a return to the name: Crabel Capital Management previously reported a position in PFE as recently as Q4 2025.

Crabel Capital Management first reported a position in PFE in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.07M in Q2 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Crabel Capital Management held 22,355 shares of Pfizer worth $538K as of Q2 2026.
Pfizer was a new Crabel Capital Management position in Q2 2026.
Pfizer made up 0.39% of Crabel Capital Management's portfolio in Q2 2026, its #34 holding.
Crabel Capital Management first reported a position in Pfizer in Q4 2019 and has held it in 12 quarters since.
Crabel Capital Management's Pfizer position peaked at $1.07M in Q2 2023.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Crabel Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.